A review published in Circulation: Cardiovascular Interventions Jan. 24 suggests adjunctive coronary atherectomy is a clinically useful and effective tool for treating severely calcified coronary lesions—but, in reality, it’s rarely used.

When the cardiac and neurovascular catheterization lab at Riverside University Health System Medical Center (RUHS-MC) treated its first patient last February, the opening represented many things to many people.

In just eight years, the world’s first completely robotic “hybrid” heart will be ready for transplant, according to the Daily Mail.

Repeat revascularization isn’t a rare occurrence after PCI or CABG, according to a study of patients with left main coronary artery disease—but it can raise a person’s risk of cardiovascular death by as much as four times.

Experts at Massachusetts General Hospital have successfully performed five CV transplants using Donation after Circulatory Death donor hearts—the largest number of adult DCD heart transplants ever completed in the U.S.

After a slow start, cardiac ERAS is gaining traction in some U.S. hospitals. Proponents explain how to overcome resistance. 

Hepatitis C-positive donor hearts are a viable long-term option for patients in need of a heart transplant, researchers confirmed in JAMA Cardiology Dec. 18.

Heart transplant patients who live in areas with high levels of air pollution had a 26% higher risk of mortality due to infection in a recent study of nearly 22,000 patients in the U.S.